MINI, ENRICO
MINI, ENRICO
Medicina Sperimentale e Clinica
1204PGOLFIG chemo-immunotherapy in metastatic colorectal cancer (mCRC) patients: A fifteen year retrospective analysis
2019 Correale, P; Staropoli, N; Pastina, P; Giannicola, R; Botta, C; Francini, E; Ridolfi, L; Mini, E; Ciliberto, D; Agostino, R M; Strangio, A; Azzarello, D; Nardone, V; Falzea, A; Tassone, P; Giordano, A; Pirtoli, L; Francini, G; Tagliaferri, P S
2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial
2015 Taieb, J.; Zaanan, A.; Malicot, K. Le; Julie, C.; Blons, H.; Mineur, L.; Tabernero, J.; Mini, E.; Folprecht, G.; Laethem, J.L. Van; Lepage, C.; Emile, J.F.; Laurent-Puig, P.
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds
2012 F. Guidi; M. Puglia; C. Gabbiani; I. Landini; T. Gamberi; D. Fregona; M.A. Cinellu; S. Nobili; E. Mini; L. Bini; P.A. Modesti; A. Modesti; L. Messori
5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro
1985 Mazzei T, Mini E, Periti P
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells
1987 Bernabei PA, Mini E, Agostino FC, Gattei V, Bezzini ER, Santini V, Saccardi R, Mazzei T, Rossi Ferrini P
6106 POSTER Immune-boost Treatment With Gemcitabine, Oxaliplatin, Levofolinate, 5-flurouracil, Granulocyte/macrophage Colony-stimulating-factor (GM-CSF) and Aldesleukine Enhances Progression-free and Overall-survival Over FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients – Early Results From the GOLFIG-2 Phase III Trial
2011 Correale, P.; Rotundo, M.S.; Botta, C.; Guglielmo, A.; Licchetta, A.; Conca, R.; Tassone, P.; Ridolfi, R.; Mini, E.; Tagliaferri, P.
[Antibiotic prophylaxis of postoperative infection in orthopedics. Results of an epidemiologic survey in Italy conducted by the Journal of Chemotherapy]
2000 Periti, P; Mini, E; Grassi, F; Cherubino, P
[Medical therapy of malignant melanoma]
1989 Mini, E; Periti, P
[Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies]
2001 A. Martoni; E. Mini; C. Pinto; A. Gentile; T. Mazzei
[Plasma and tissue antibiotic concentrations: what is their prognostic value?]
1992 Mazzei, T; Novelli, A; Mini, E; Periti, P
[Relation of pharmacokinetics and toxicity of methotrexate at high dose]
1979 Mini, E; Mazzei, T; Ciuffi, M; Ruggeri, M; Benini, A; Carniani, E
[The role of amikacin in conditions requiring chemotherapy with aminoglycoside antibiotics]
1979 Mazzei, T; Ciuffi, M; Nicoletti, P; Panero, C; Mainardi, G C; Mini, E; Versari, L
A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin
2023 Cosso, Federica; Roviello, Giandomenico; Catalano, Martina; Botteri, Cristina; Comin, Camilla Eva; Castiglione, Francesca; Ferrari, Katia; Baldini, Editta; Mini, Enrico
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma.
2018 Lavacchi D, Nobili S, Brugia M, Paderi A, Fancelli S, Caliman E, Vergoni F, Mini E.
A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy.
2018 De Mattia E, Dreussi E, Montico M, Gagno S, Zanusso C, Quartuccio L, De Vita S, Guardascione M, Buonadonna A, D'Andrea M, Pella N, Favaretto A, Mini E, Nobili S, Romanato L, Cecchin E, Toffoli G.
A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion
1993 Periti P, Stringa G, Mazzei T, Mini E, Novelli A, Calviani L
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells.
1995 A. Arcangeli; L. Bianchi; A. Becchetti; L. Faravelli; M. Coronnello; E. Mini; M. Olivotto; E. Wanke
A pharmacogenetics UGT1A1 dose-escalation study of irinotecan in colorectal cancer (CRC) patients (pts) treated with the FOLFIRI regimen.
2008 Toffoli G, Cecchin E, D'Andrea M, Azzarello G, Buonadonna A, Mini E, Tumolo S, Pessa S, Pasetto LM
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development
2019 Roviello G.; Nobili S.; Mini E.
A randomized multicenter study comparing 5-fluorouracil (5-FU) and l-folinic acid (L-LV) alone or with levamisole (LEV) or interferon alpha2a (IFNalpha2a) as adjuvant therapy for colorectal cancer
1996 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P